Your browser doesn't support javascript.
loading
African American race as a risk factor associated with a second primary lung cancer after initial primary head and neck cancer.
Shao, Yusra F; Kim, Seongho; Cramer, John D; Farhat, Dina; Hotaling, Jeffrey; Raza, Syed Naweed; Yoo, George; Lin, Ho-Sheng; Kim, Harold; Sukari, Ammar; Nagasaka, Misako.
Afiliação
  • Shao YF; Department of Oncology, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, Michigan, USA.
  • Kim S; Department of Oncology, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, Michigan, USA.
  • Cramer JD; Department of Otolaryngology - Head and Neck Surgery, Wayne State University School of Medicine, Detroit, Michigan, USA.
  • Farhat D; Department of Oncology, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, Michigan, USA.
  • Hotaling J; Department of Otolaryngology - Head and Neck Surgery, Wayne State University School of Medicine, Detroit, Michigan, USA.
  • Raza SN; Department of Otolaryngology - Head and Neck Surgery, Wayne State University School of Medicine, Detroit, Michigan, USA.
  • Yoo G; Department of Otolaryngology - Head and Neck Surgery, Wayne State University School of Medicine, Detroit, Michigan, USA.
  • Lin HS; Department of Otolaryngology - Head and Neck Surgery, Wayne State University School of Medicine, Detroit, Michigan, USA.
  • Kim H; Department of Radiation Oncology, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, Michigan, USA.
  • Sukari A; Department of Oncology, Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, Michigan, USA.
  • Nagasaka M; Division of Hematology and Oncology, Department of Medicine, University of California Irvine School of Medicine, Orange, CA, USA.
Head Neck ; 44(10): 2069-2076, 2022 10.
Article em En | MEDLINE | ID: mdl-35713967
ABSTRACT

BACKGROUND:

Initial primary head and neck cancer (IPHNC) is associated with second primary lung cancer (SPLC). We studied this association in a population with a high proportion of African American (AA) patients.

METHODS:

Patients with IPHNC and SPLC treated between 2000 and 2017 were reviewed for demographic, disease, and treatment-related characteristics and compared to age-and-stage-matched controls without SPLC. Logistic and Cox regression models were used to analyze the relationship of these characteristics with the development of SPLC and overall survival (OS).

RESULTS:

Eighty-seven patients and controls were compared respectively. AA race was associated with a significantly higher risk of developing SPLC (OR 2.92, 95% CI 1.35-6.66). After correcting for immortal time bias, patients with SPLC had a significantly lower OS when compared with controls (HR 0.248, 95% CI 0.170-0.362).

CONCLUSIONS:

We show that AA race is associated with an increased risk of SPLC after IPHNC; reasons of this increased risk warrant further investigation.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Segunda Neoplasia Primária / Neoplasias de Cabeça e Pescoço / Neoplasias Pulmonares Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Segunda Neoplasia Primária / Neoplasias de Cabeça e Pescoço / Neoplasias Pulmonares Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article